Page 136 - Mployee Wellness Programs News Today

Retail clinic claims volumes have shot up by 200% in the past five years, according to a new report. The research argued that retailers are beginning to seriously compete with the traditional healthcare system when it comes to the primary care market — growth in retail clinic claims have greatly outpaced claims growth for urgent care centers, emergency departments and physician practices.

By selling U.S. rights to Yutiq, EyePoint Pharmaceuticals gets $75 million cash to support its drug pipeline. The company’s lead product candidate is in mid-stage development for wet age-related macular degeneration and non-proliferative diabetic retinopathy.

Malla, a startup that launched Wednesday, is trying to make functional, personalized medicine more accessible. Consumers can purchase a membership, which includes one-on-one video sessions with a practitioner, messaging, personalized care plans and tracking.

1115 waivers offer states a way to test new approaches in Medicaid that differ from what is required by federal statute. As we look at states leveraging Section 1115 Eligibility Changes, take notice of a strong emphasis on the justice-involved, housing/homelessness, and behavioral health.

In a wide-ranging interview, Sanford Health's president of virtual care explained how virtual care may be well suited to rural populations.

Five companies will take part in the showcase with technologies addressing mental health, care coordination, aging in place, physical therapy and more. Register for INVEST, scheduled for May 22-24, at the Ritz Carlton in Chicago!

Blue Cross Blue Shield of Massachusetts has added Eden Health, On Belay Health Solutions and VillageMD to its primary care network. The physician groups will provide both virtual and in-person care to members.

Suki recently announced one of its biggest partnerships to date: it is integrating its voice assistant into Epic’s EHR. The startup's assistant can be thought of as like Apple’s Siri or Amazon’s Alexa — but for doctors.

CVS Health is winding down its clinical trials business, with a full exit expected by December 31, 2024, the company confirmed to MedCity News. But decentralized clinical trials still have an important role to play, said Brian Weiss, CEO of Carebox.

PTC Therapeutics plans to talk to regulators about regulatory submissions for sepiapterin after the drug met the main goal of a Phase 3 study. The small molecule is a potential treatment for phenylketonuria, a rare enzyme deficiency.